These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8684425)
21. Resistant mechanisms of Candida albicans to fluconazole. Wang W; Li R; Wang D; Li S; Zhu L; Wang X; Wan Z; Zhai W Chin Med J (Engl); 1999 May; 112(5):466-71. PubMed ID: 11593521 [TBL] [Abstract][Full Text] [Related]
22. Effect of iron on fluconazole activity against Candida albicans in presence of human serum or monocyte-derived macrophages. Minn Y; Brummer E; Stevens DA Mycopathologia; 1997; 138(1):29-35. PubMed ID: 9404022 [TBL] [Abstract][Full Text] [Related]
23. Interaction of Candida albicans, macrophages and fluconazole: in vitro and ex vivo observations. Tullio V; Cuffini AM; De Leo C; Perrone F; Carlone NA J Chemother; 1996 Dec; 8(6):438-44. PubMed ID: 8981184 [TBL] [Abstract][Full Text] [Related]
24. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans. De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140 [TBL] [Abstract][Full Text] [Related]
26. Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans. Ponce E; Pechère JC Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):738-44. PubMed ID: 2175704 [TBL] [Abstract][Full Text] [Related]
27. Liposomal thymoquinone effectively combats fluconazole-resistant Candida albicans in a murine model. Khan MA; Aljarbou AN; Khan A; Younus H Int J Biol Macromol; 2015 May; 76():203-8. PubMed ID: 25709021 [TBL] [Abstract][Full Text] [Related]
28. Macrophage colony-stimulating factor (M-CSF) induction of enhanced anticryptococcal activity in human monocyte-derived macrophages: synergy with fluconazole for killing. Nassar F; Brummer E; Stevens DA Cell Immunol; 1995 Aug; 164(1):113-8. PubMed ID: 7634342 [TBL] [Abstract][Full Text] [Related]
29. ZD0870 treatment of murine candidiasis caused by fluconazole resistant isolates of Candida albicans. Najvar LK; Correa A; James P; Luther MF; Graybill JR J Antimicrob Chemother; 1996 Oct; 38(4):671-7. PubMed ID: 8937961 [TBL] [Abstract][Full Text] [Related]
30. In vitro activity of fluconazole on Candida albicans. Abecia LC; Arévalo JM; López MJ Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696 [TBL] [Abstract][Full Text] [Related]
31. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans. Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309 [TBL] [Abstract][Full Text] [Related]
32. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
33. Time-Kill Kinetics of Rezafungin (CD101) in Vagina-Simulative Medium for Fluconazole-Susceptible and Fluconazole-Resistant Locke JB; Almaguer AL; Donatelli JL; Bartizal KF Infect Dis Obstet Gynecol; 2018; 2018():7040498. PubMed ID: 29681727 [TBL] [Abstract][Full Text] [Related]
34. The Etest Performed Directly on Blood Culture Bottles Is a Reliable Tool for Detection of Fluconazole-Resistant Candida albicans Isolates. Escribano P; Marcos-Zambrano LJ; Gómez A; Sánchez C; Martínez-Jiménez MC; Bouza E; Guinea J Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483951 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model. González GM; Robledo E; Saldívar D; González G; Bosques F; Garza E Med Mycol; 2007 May; 45(3):221-4. PubMed ID: 17464843 [TBL] [Abstract][Full Text] [Related]
36. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso). Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462 [TBL] [Abstract][Full Text] [Related]
37. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans. Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344 [TBL] [Abstract][Full Text] [Related]
38. Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth. Wibawa T; Nurrokhman ; Baly I; Daeli PR; Kartasasmita G; Wijayanti N Trop Biomed; 2015 Mar; 32(1):176-82. PubMed ID: 25801268 [TBL] [Abstract][Full Text] [Related]